HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 258 filers reported holding HAEMONETICS CORP in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,670,899 | +3.0% | 40,979 | -2.1% | 0.01% | +11.1% |
Q2 2023 | $3,565,238 | +475.5% | 41,875 | +459.4% | 0.01% | +350.0% |
Q1 2023 | $619,466 | +0.3% | 7,486 | -4.6% | 0.00% | 0.0% |
Q4 2022 | $617,403 | -11.8% | 7,850 | -17.1% | 0.00% | 0.0% |
Q3 2022 | $700,000 | -4.9% | 9,464 | -16.2% | 0.00% | 0.0% |
Q2 2022 | $736,000 | -97.5% | 11,291 | -97.6% | 0.00% | -97.0% |
Q1 2022 | $29,245,000 | +287.2% | 462,586 | +224.8% | 0.07% | +371.4% |
Q4 2021 | $7,553,000 | +968.3% | 142,402 | +1322.5% | 0.01% | +1300.0% |
Q3 2021 | $707,000 | +72.9% | 10,011 | +63.3% | 0.00% | 0.0% |
Q2 2021 | $409,000 | -63.5% | 6,132 | -39.2% | 0.00% | -50.0% |
Q1 2021 | $1,120,000 | -10.0% | 10,091 | -3.7% | 0.00% | -33.3% |
Q4 2020 | $1,244,000 | -74.0% | 10,474 | -80.9% | 0.00% | -72.7% |
Q3 2020 | $4,788,000 | -30.2% | 54,884 | -28.3% | 0.01% | -35.3% |
Q2 2020 | $6,857,000 | +339.3% | 76,554 | +388.7% | 0.02% | +240.0% |
Q1 2020 | $1,561,000 | -85.8% | 15,666 | -83.7% | 0.01% | -80.0% |
Q4 2019 | $11,012,000 | +1.5% | 95,835 | +11.4% | 0.02% | -7.4% |
Q3 2019 | $10,850,000 | +436.1% | 86,015 | +411.5% | 0.03% | +440.0% |
Q2 2019 | $2,024,000 | +3.0% | 16,815 | -25.2% | 0.01% | 0.0% |
Q1 2019 | $1,966,000 | -84.6% | 22,473 | -82.4% | 0.01% | -85.7% |
Q4 2018 | $12,775,000 | -32.3% | 127,692 | -22.5% | 0.04% | -20.5% |
Q3 2018 | $18,875,000 | +19.0% | 164,734 | -6.8% | 0.04% | -4.3% |
Q2 2018 | $15,857,000 | +49.2% | 176,819 | +21.7% | 0.05% | +48.4% |
Q1 2018 | $10,628,000 | +15529.4% | 145,268 | +12358.7% | 0.03% | – |
Q4 2017 | $68,000 | +25.9% | 1,166 | -2.6% | 0.00% | – |
Q3 2017 | $54,000 | +8.0% | 1,197 | -6.0% | 0.00% | – |
Q2 2017 | $50,000 | -2.0% | 1,274 | +1.3% | 0.00% | – |
Q1 2017 | $51,000 | -12.1% | 1,258 | -12.6% | 0.00% | – |
Q4 2016 | $58,000 | 0.0% | 1,440 | -9.5% | 0.00% | – |
Q3 2016 | $58,000 | +5.5% | 1,591 | -15.6% | 0.00% | – |
Q2 2016 | $55,000 | -24.7% | 1,886 | -10.2% | 0.00% | – |
Q1 2016 | $73,000 | +7.4% | 2,100 | 0.0% | 0.00% | – |
Q4 2015 | $68,000 | +1033.3% | 2,100 | +1113.9% | 0.00% | – |
Q4 2014 | $6,000 | 0.0% | 173 | -6.5% | 0.00% | – |
Q3 2014 | $6,000 | -90.3% | 185 | -89.5% | 0.00% | – |
Q2 2014 | $62,000 | -27.1% | 1,757 | -33.0% | 0.00% | – |
Q1 2014 | $85,000 | +304.8% | 2,621 | +427.4% | 0.00% | – |
Q4 2013 | $21,000 | – | 497 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LGT CAPITAL PARTNERS LTD. | 1,216,059 | $64,500,000 | 1.72% |
HEARTLAND ADVISORS INC | 406,192 | $21,544,000 | 1.26% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $10,608,000 | 1.22% |
Aurora Investment Counsel | 32,149 | $1,705,000 | 1.01% |
Endurant Capital Management LP | 73,914 | $3,920,000 | 0.95% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 135,000 | $7,160,000 | 0.82% |
ARMISTICE CAPITAL, LLC | 872,000 | $46,251,000 | 0.76% |
Summit Creek Advisors LLC | 131,357 | $6,967,000 | 0.70% |
Dean Capital Management | 15,309 | $812,000 | 0.70% |
Keene & Associates, Inc. | 11,720 | $622,000 | 0.54% |